Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 48 entries
Sorted by: Best Match Show Resources per page
External dacryocystorhinostomy in consultants and fellows - a comparison of the causes of failure.

Hippokratia

Sullivan L, Fearnley T, Al-Maskari A, El-Hindy N, Kalantzis G, Chang BY.
PMID: 27418779
Hippokratia. 2015 Jul-Sep;19(3):216-8.

PURPOSE: Failure of primary dacryocystorhinostomy (DCR) often requires revision surgery to inspect the cause of failure and re-establish anatomic patency. This study aims to specifcally compare the anatomical causes of failure noted during revision DCR of primary external DCR...

Cite
Sullivan L, Fearnley T, Al-Maskari A, et al. External dacryocystorhinostomy in consultants and fellows - a comparison of the causes of failure. Hippokratia. 2015;19(3):216-8
Sullivan, L., Fearnley, T., Al-Maskari, A., El-Hindy, N., Kalantzis, G., & Chang, B. Y. (2015). External dacryocystorhinostomy in consultants and fellows - a comparison of the causes of failure. Hippokratia, 19(3), 216-8.
Sullivan, L, et al. "External dacryocystorhinostomy in consultants and fellows - a comparison of the causes of failure." Hippokratia vol. 19,3 (2015): 216-8.
Sullivan L, Fearnley T, Al-Maskari A, El-Hindy N, Kalantzis G, Chang BY. External dacryocystorhinostomy in consultants and fellows - a comparison of the causes of failure. Hippokratia. 2015 Jul-Sep;19(3):216-8. PMID: 27418779; PMCID: PMC4938467.
Copy Download .nbib Format: NLM
VEGF-A isoform-specific regulation of calcium ion flux, transcriptional activation and endothelial cell migration.

Biology open

Fearnley GW, Bruns AF, Wheatcroft SB, Ponnambalam S.
PMID: 25910937
Biol Open. 2015 Apr 24;4(6):731-42. doi: 10.1242/bio.201410884.

Vascular endothelial growth factor A (VEGF-A) regulates many aspects of vascular physiology such as cell migration, proliferation, tubulogenesis and cell-cell interactions. Numerous isoforms of VEGF-A exist but their physiological significance is unclear. Here we evaluated two different VEGF-A isoforms...

Cite
Fearnley GW, Bruns AF, Wheatcroft SB, et al. VEGF-A isoform-specific regulation of calcium ion flux, transcriptional activation and endothelial cell migration. Biol Open. 2015;4(6):731-42doi: 10.1242/bio.201410884.
Fearnley, G. W., Bruns, A. F., Wheatcroft, S. B., & Ponnambalam, S. (2015). VEGF-A isoform-specific regulation of calcium ion flux, transcriptional activation and endothelial cell migration. Biology open, 4(6), 731-42. https://doi.org/10.1242/bio.201410884
Fearnley, Gareth W, et al. "VEGF-A isoform-specific regulation of calcium ion flux, transcriptional activation and endothelial cell migration." Biology open vol. 4,6 (2015): 731-42. doi: https://doi.org/10.1242/bio.201410884
Fearnley GW, Bruns AF, Wheatcroft SB, Ponnambalam S. VEGF-A isoform-specific regulation of calcium ion flux, transcriptional activation and endothelial cell migration. Biol Open. 2015 Apr 24;4(6):731-42. doi: 10.1242/bio.201410884. PMID: 25910937; PMCID: PMC4467193.
Copy Download .nbib Format: NLM
Fibrinolysis.

Journal of clinical pathology

Fearnley GR.
PMID: 16811017
J Clin Pathol. 1964 May;17(3):305-6. doi: 10.1136/jcp.17.3.305.

No abstract available.

Cite
Fearnley GR. Fibrinolysis. J Clin Pathol. 1964;17(3):305-6doi: 10.1136/jcp.17.3.305.
Fearnley, G. R. (1964). Fibrinolysis. Journal of clinical pathology, 17(3), 305-6. https://doi.org/10.1136/jcp.17.3.305
Fearnley, G R. "Fibrinolysis." Journal of clinical pathology vol. 17,3 (1964): 305-6. doi: https://doi.org/10.1136/jcp.17.3.305
Fearnley GR. Fibrinolysis. J Clin Pathol. 1964 May;17(3):305-6. doi: 10.1136/jcp.17.3.305. PMID: 16811017; PMCID: PMC480753.
Copy Download .nbib Format: NLM
Potentiating antimicrobial efficacy of propolis through niosomal-based system for administration.

Integrative medicine research

Patel J, Ketkar S, Patil S, Fearnley J, Mahadik KR, Paradkar AR.
PMID: 28664114
Integr Med Res. 2015 Jun;4(2):94-101. doi: 10.1016/j.imr.2014.10.004. Epub 2014 Oct 30.

METHODS: Propolis was extracted in ethanol and screened for total polyphenol content. Propolis-loaded niosomes (PLNs) were prepared with varying concentrations of Span 60 and cholesterol. The PLNs were evaluated for physicochemical parameters, namely, vesicle size, entrapment efficiency, zeta potential,...

Cite
Patel J, Ketkar S, Patil S, et al. Potentiating antimicrobial efficacy of propolis through niosomal-based system for administration. Integr Med Res. 2014;4(2):94-101doi: 10.1016/j.imr.2014.10.004.
Patel, J., Ketkar, S., Patil, S., Fearnley, J., Mahadik, K. R., & Paradkar, A. R. (2015). Potentiating antimicrobial efficacy of propolis through niosomal-based system for administration. Integrative medicine research, 4(2), 94-101. https://doi.org/10.1016/j.imr.2014.10.004
Patel, Jay, et al. "Potentiating antimicrobial efficacy of propolis through niosomal-based system for administration." Integrative medicine research vol. 4,2 (2015): 94-101. doi: https://doi.org/10.1016/j.imr.2014.10.004
Patel J, Ketkar S, Patil S, Fearnley J, Mahadik KR, Paradkar AR. Potentiating antimicrobial efficacy of propolis through niosomal-based system for administration. Integr Med Res. 2015 Jun;4(2):94-101. doi: 10.1016/j.imr.2014.10.004. Epub 2014 Oct 30. PMID: 28664114; PMCID: PMC5481798.
Copy Download .nbib Format: NLM
Parental Life-Limiting Illness: What Do We Tell the Children?.

Healthcare (Basel, Switzerland)

Fearnley R, Boland JW.
PMID: 30897857
Healthcare (Basel). 2019 Mar 20;7(1). doi: 10.3390/healthcare7010047.

Being diagnosed with and having a life-limiting illness is a stressful experience which is compounded when the patient has dependent children. An important aspect of the patient's psychosocial care should include recognition that their children are also likely to...

Cite
Fearnley R, Boland JW. Parental Life-Limiting Illness: What Do We Tell the Children?. Healthcare (Basel). 2019;7(1)doi: 10.3390/healthcare7010047.
Fearnley, R., & Boland, J. W. (2019). Parental Life-Limiting Illness: What Do We Tell the Children?. Healthcare (Basel, Switzerland), 7(1), . https://doi.org/10.3390/healthcare7010047
Fearnley, Rachel, and Boland, Jason W. "Parental Life-Limiting Illness: What Do We Tell the Children?." Healthcare (Basel, Switzerland) vol. 7,1 (2019). doi: https://doi.org/10.3390/healthcare7010047
Fearnley R, Boland JW. Parental Life-Limiting Illness: What Do We Tell the Children?. Healthcare (Basel). 2019 Mar 20;7(1). doi: 10.3390/healthcare7010047. PMID: 30897857; PMCID: PMC6473248.
Copy Download .nbib Format: NLM
Multistate Outbreak of Salmonella enterica Serovar Heidelberg with Unidentified Source, Australia, 2018-2019.

Emerging infectious diseases

Kerr EJ, Stafford R, Rathnayake IU, Graham RMA, Fearnley E, Gregory J, Glasgow K, Wright R, Sintchenko V, Wang Q, Howard P, Leong LEX, Valcanis M, Pitchers W, Lambert SB, Jennison AV.
PMID: 34932458
Emerg Infect Dis. 2022 Jan;28(1):238-241. doi: 10.3201/eid2801.211462.

We report a multistate Salmonella enterica serovar Heidelberg outbreak in Australia during 2018-2019. Laboratory investigation of cases reported across 5 jurisdictions over a 7-month period could not identify a source of infection but detected indicators of severity and invasiveness....

Cite
Kerr EJ, Stafford R, Rathnayake IU, et al. Multistate Outbreak of Salmonella enterica Serovar Heidelberg with Unidentified Source, Australia, 2018-2019. Emerg Infect Dis. 2022;28(1):238-241doi: 10.3201/eid2801.211462.
Kerr, E. J., Stafford, R., Rathnayake, I. U., Graham, R. M. A., Fearnley, E., Gregory, J., Glasgow, K., Wright, R., Sintchenko, V., Wang, Q., Howard, P., Leong, L. E. X., Valcanis, M., Pitchers, W., Lambert, S. B., & Jennison, A. V. (2022). Multistate Outbreak of Salmonella enterica Serovar Heidelberg with Unidentified Source, Australia, 2018-2019. Emerging infectious diseases, 28(1), 238-241. https://doi.org/10.3201/eid2801.211462
Kerr, Elenor J, et al. "Multistate Outbreak of Salmonella enterica Serovar Heidelberg with Unidentified Source, Australia, 2018-2019." Emerging infectious diseases vol. 28,1 (2022): 238-241. doi: https://doi.org/10.3201/eid2801.211462
Kerr EJ, Stafford R, Rathnayake IU, Graham RMA, Fearnley E, Gregory J, Glasgow K, Wright R, Sintchenko V, Wang Q, Howard P, Leong LEX, Valcanis M, Pitchers W, Lambert SB, Jennison AV. Multistate Outbreak of Salmonella enterica Serovar Heidelberg with Unidentified Source, Australia, 2018-2019. Emerg Infect Dis. 2022 Jan;28(1):238-241. doi: 10.3201/eid2801.211462. PMID: 34932458; PMCID: PMC8714228.
Copy Download .nbib Format: NLM
Antiviral, Antibacterial, Antifungal, and Antiparasitic Properties of Propolis: A Review.

Foods (Basel, Switzerland)

Zulhendri F, Chandrasekaran K, Kowacz M, Ravalia M, Kripal K, Fearnley J, Perera CO.
PMID: 34208334
Foods. 2021 Jun 11;10(6). doi: 10.3390/foods10061360.

Propolis is a complex phytocompound made from resinous and balsamic material harvested by bees from flowers, branches, pollen, and tree exudates. Humans have used propolis therapeutically for centuries. The aim of this article is to provide comprehensive review of...

Cite
Zulhendri F, Chandrasekaran K, Kowacz M, et al. Antiviral, Antibacterial, Antifungal, and Antiparasitic Properties of Propolis: A Review. Foods. 2021;10(6)doi: 10.3390/foods10061360.
Zulhendri, F., Chandrasekaran, K., Kowacz, M., Ravalia, M., Kripal, K., Fearnley, J., & Perera, C. O. (2021). Antiviral, Antibacterial, Antifungal, and Antiparasitic Properties of Propolis: A Review. Foods (Basel, Switzerland), 10(6), . https://doi.org/10.3390/foods10061360
Zulhendri, Felix, et al. "Antiviral, Antibacterial, Antifungal, and Antiparasitic Properties of Propolis: A Review." Foods (Basel, Switzerland) vol. 10,6 (2021). doi: https://doi.org/10.3390/foods10061360
Zulhendri F, Chandrasekaran K, Kowacz M, Ravalia M, Kripal K, Fearnley J, Perera CO. Antiviral, Antibacterial, Antifungal, and Antiparasitic Properties of Propolis: A Review. Foods. 2021 Jun 11;10(6). doi: 10.3390/foods10061360. PMID: 34208334; PMCID: PMC8231288.
Copy Download .nbib Format: NLM
Propolis in Metabolic Syndrome and Its Associated Chronic Diseases: A Narrative Review.

Antioxidants (Basel, Switzerland)

Zulhendri F, Ravalia M, Kripal K, Chandrasekaran K, Fearnley J, Perera CO.
PMID: 33652692
Antioxidants (Basel). 2021 Feb 26;10(3). doi: 10.3390/antiox10030348.

Propolis is a resinous product collected by bees from plants to protect and maintain the homeostasis of their hives. Propolis has been used therapeutically by humans for centuries. This review article attempts to analyze the potential use of propolis...

Cite
Zulhendri F, Ravalia M, Kripal K, et al. Propolis in Metabolic Syndrome and Its Associated Chronic Diseases: A Narrative Review. Antioxidants (Basel). 2021;10(3)doi: 10.3390/antiox10030348.
Zulhendri, F., Ravalia, M., Kripal, K., Chandrasekaran, K., Fearnley, J., & Perera, C. O. (2021). Propolis in Metabolic Syndrome and Its Associated Chronic Diseases: A Narrative Review. Antioxidants (Basel, Switzerland), 10(3), . https://doi.org/10.3390/antiox10030348
Zulhendri, Felix, et al. "Propolis in Metabolic Syndrome and Its Associated Chronic Diseases: A Narrative Review." Antioxidants (Basel, Switzerland) vol. 10,3 (2021). doi: https://doi.org/10.3390/antiox10030348
Zulhendri F, Ravalia M, Kripal K, Chandrasekaran K, Fearnley J, Perera CO. Propolis in Metabolic Syndrome and Its Associated Chronic Diseases: A Narrative Review. Antioxidants (Basel). 2021 Feb 26;10(3). doi: 10.3390/antiox10030348. PMID: 33652692; PMCID: PMC7996839.
Copy Download .nbib Format: NLM
Measuring pathway database coverage of the phosphoproteome.

PeerJ

Huckstep H, Fearnley LG, Davis MJ.
PMID: 34113485
PeerJ. 2021 May 25;9:e11298. doi: 10.7717/peerj.11298. eCollection 2021.

Protein phosphorylation is one of the best known post-translational mechanisms playing a key role in the regulation of cellular processes. Over 100,000 distinct phosphorylation sites have been discovered through constant improvement of mass spectrometry based phosphoproteomics in the last...

Cite
Huckstep H, Fearnley LG, Davis MJ. Measuring pathway database coverage of the phosphoproteome. PeerJ. 2021;9:e11298doi: 10.7717/peerj.11298.
Huckstep, H., Fearnley, L. G., & Davis, M. J. (2021). Measuring pathway database coverage of the phosphoproteome. PeerJ, 9e11298. https://doi.org/10.7717/peerj.11298
Huckstep, Hannah, et al. "Measuring pathway database coverage of the phosphoproteome." PeerJ vol. 9 (2021): e11298. doi: https://doi.org/10.7717/peerj.11298
Huckstep H, Fearnley LG, Davis MJ. Measuring pathway database coverage of the phosphoproteome. PeerJ. 2021 May 25;9:e11298. doi: 10.7717/peerj.11298. eCollection 2021. PMID: 34113485; PMCID: PMC8162239.
Copy Download .nbib Format: NLM
Developing the geographic classification for health, a rural-urban classification for New Zealand health research and policy: A research protocol.

The Australian journal of rural health

Nixon G, Whitehead J, Davie G, Fearnley D, Crengle S, de Graaf B, Smith M, Wakerman J, Lawrenson R.
PMID: 34494690
Aust J Rural Health. 2021 Dec;29(6):939-946. doi: 10.1111/ajr.12778. Epub 2021 Sep 08.

INTRODUCTION: Rural-urban health inequities, exacerbated by deprivation and ethnicity, have been clearly described in the international literature. To date, the same inequities have not been as clearly demonstrated in Aotearoa New Zealand despite the lower socioeconomic status and higher...

Cite
Nixon G, Whitehead J, Davie G, et al. Developing the geographic classification for health, a rural-urban classification for New Zealand health research and policy: A research protocol. Aust J Rural Health. 2021;29(6):939-946doi: 10.1111/ajr.12778.
Nixon, G., Whitehead, J., Davie, G., Fearnley, D., Crengle, S., de Graaf, B., Smith, M., Wakerman, J., & Lawrenson, R. (2021). Developing the geographic classification for health, a rural-urban classification for New Zealand health research and policy: A research protocol. The Australian journal of rural health, 29(6), 939-946. https://doi.org/10.1111/ajr.12778
Nixon, Garry, et al. "Developing the geographic classification for health, a rural-urban classification for New Zealand health research and policy: A research protocol." The Australian journal of rural health vol. 29,6 (2021): 939-946. doi: https://doi.org/10.1111/ajr.12778
Nixon G, Whitehead J, Davie G, Fearnley D, Crengle S, de Graaf B, Smith M, Wakerman J, Lawrenson R. Developing the geographic classification for health, a rural-urban classification for New Zealand health research and policy: A research protocol. Aust J Rural Health. 2021 Dec;29(6):939-946. doi: 10.1111/ajr.12778. Epub 2021 Sep 08. PMID: 34494690.
Copy Download .nbib Format: NLM
Spatiotemporal expression of IgLON family members in the developing mouse nervous system.

Scientific reports

Fearnley S, Raja R, Cloutier JF.
PMID: 34599206
Sci Rep. 2021 Oct 01;11(1):19536. doi: 10.1038/s41598-021-97768-5.

Differential expression of cell adhesion molecules in neuronal populations is one of the many mechanisms promoting the formation of functional neural circuits in the developing nervous system. The IgLON family consists of five cell surface immunoglobulin proteins that have...

Cite
Fearnley S, Raja R, Cloutier JF. Spatiotemporal expression of IgLON family members in the developing mouse nervous system. Sci Rep. 2021;11(1):19536doi: 10.1038/s41598-021-97768-5.
Fearnley, S., Raja, R., & Cloutier, J. F. (2021). Spatiotemporal expression of IgLON family members in the developing mouse nervous system. Scientific reports, 11(1), 19536. https://doi.org/10.1038/s41598-021-97768-5
Fearnley, Sydney, et al. "Spatiotemporal expression of IgLON family members in the developing mouse nervous system." Scientific reports vol. 11,1 (2021): 19536. doi: https://doi.org/10.1038/s41598-021-97768-5
Fearnley S, Raja R, Cloutier JF. Spatiotemporal expression of IgLON family members in the developing mouse nervous system. Sci Rep. 2021 Oct 01;11(1):19536. doi: 10.1038/s41598-021-97768-5. PMID: 34599206; PMCID: PMC8486791.
Copy Download .nbib Format: NLM
Tpl2 is required for VEGF-A-stimulated signal transduction and endothelial cell function.

Biology open

Fearnley GW, Abdul-Zani I, Latham AM, Hollstein MC, Ladbury JE, Wheatcroft SB, Odell AF, Ponnambalam S.
PMID: 31072823
Biol Open. 2019 May 17;8(5). doi: 10.1242/bio.034215.

New blood vessel sprouting (angiogenesis) and vascular physiology are fundamental features of metazoan species but we do not fully understand how signal transduction pathways regulate diverse vascular responses. The vascular endothelial growth factor (VEGF) family bind membrane-bound receptor tyrosine...

Cite
Fearnley GW, Abdul-Zani I, Latham AM, et al. Tpl2 is required for VEGF-A-stimulated signal transduction and endothelial cell function. Biol Open. 2019;8(5)doi: 10.1242/bio.034215.
Fearnley, G. W., Abdul-Zani, I., Latham, A. M., Hollstein, M. C., Ladbury, J. E., Wheatcroft, S. B., Odell, A. F., & Ponnambalam, S. (2019). Tpl2 is required for VEGF-A-stimulated signal transduction and endothelial cell function. Biology open, 8(5), . https://doi.org/10.1242/bio.034215
Fearnley, Gareth W, et al. "Tpl2 is required for VEGF-A-stimulated signal transduction and endothelial cell function." Biology open vol. 8,5 (2019). doi: https://doi.org/10.1242/bio.034215
Fearnley GW, Abdul-Zani I, Latham AM, Hollstein MC, Ladbury JE, Wheatcroft SB, Odell AF, Ponnambalam S. Tpl2 is required for VEGF-A-stimulated signal transduction and endothelial cell function. Biol Open. 2019 May 17;8(5). doi: 10.1242/bio.034215. PMID: 31072823; PMCID: PMC6550078.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 48 entries